Subsequently, we studied the relationships between differential expression of COL11A1 and the corresponding T status, N status, M status, clinical stage, ER status, PR status, HER-2 status, PAM50 status, histological types and menopause status in breast cancer patients. This evidence concerns the gene ERBB2 and breast carcinoma.